3D Quantification of Viral Transduction Efficiency in Living Human Retinal Organoids
Open Access
- 12 June 2025
- journal article
- Published by Wiley in Small Methods
- Vol. 10 (2) , e2401050
Abstract
The development of therapeutics builds on testing their efficiency in vitro. To optimize gene therapies, for example, fluorescent reporters expressed by treated cells are typically utilized as readouts. Traditionally, their global fluorescence signal has been used as an estimate of transduction efficiency. However, analysis in individual cells within a living 3D tissue remains a challenge. Readout on a single‐cell level can be realized via fluorescence‐based flow cytometry at the cost of tissue dissociation and loss of spatial information. Complementary, spatial information is accessible via immunofluorescence of fixed samples. Both approaches impede time‐dependent studies on the delivery of the vector to the cells. Here, quantitative 3D characterization of viral transduction efficiencies in living retinal organoids is introduced. The approach combines quantification of gene delivery efficiency in space and time, leveraging human retinal organoids, engineered adeno‐associated virus (AAV) vectors, confocal live imaging, and deep learning‐based image segmentation. The integration of these tools in an organoid imaging and analysis pipeline allows quantitative testing of future treatments and other gene delivery methods. It has the potential to guide the development of therapies in biomedical applications.Keywords
All Related Versions
Funding Information
- Deutsche Forschungsgemeinschaft (513025799)
- HORIZON EUROPE European Research Council (850691)
This publication has 32 references indexed in Scilit:
- Cone photoreceptors in human stem cell-derived retinal organoids demonstrate intrinsic light responses that mimic those of primate foveaCell Stem Cell, 2022
- Together is Better: mRNA Co‐Encapsulation in Lipoplexes is Required to Obtain Ratiometric Co‐Delivery and Protein Expression on the Single Cell LevelAdvanced Science, 2021
- Human stem cell-based retina on chip as new translational model for validation of AAV retinal gene therapy vectorsStem Cell Reports, 2021
- Clinical Perspective: Treating RPE65-Associated Retinal DystrophyMolecular Therapy, 2021
- Cell Types of the Human Retina and Its Organoids at Single-Cell ResolutionCell, 2020
- Pluripotent stem cell-derived retinal organoids for disease modeling and development of therapiesStem Cells, 2020
- Decellularised extracellular matrix-derived peptides from neural retina and retinal pigment epithelium enhance the expression of synaptic markers and light responsiveness of human pluripotent stem cell derived retinal organoidsBiomaterials, 2019
- Human-Induced Pluripotent Stem Cells Generate Light Responsive Retinal Organoids with Variable and Nutrient-Dependent EfficiencyStem Cells, 2018
- Self-Formation of Optic Cups and Storable Stratified Neural Retina from Human ESCsCell Stem Cell, 2012
- Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiencyThe Journal of Gene Medicine, 2005